Dr. Irving Selikoff
Executive Summary
Historians McCulloch and Tweedale describe Dr. Irving J. Selikoff as "the leading American medical expert on asbestos-related diseases between the 1960s and early 1990s".[1] His landmark 1964 study of more than 600 asbestos insulation workers documented the toll of asbestos, including mesothelioma, in an American workforce: among 632 insulation workers traced through 1962, 45 died of cancer of the lung or pleura where 6.6 such deaths were expected, a 6.8-fold excess of deaths from that cancer specifically.[2] McCulloch and Tweedale also write that "for much of his career he was the victim of a sustained and orchestrated campaign to discredit him".[1]
Selikoff lived from 1915 to 1992.[1] His research followed asbestos insulation workers over decades: one study observed 17,800 of them prospectively from 1 January 1967 to 1 January 1987.[3]
The implications of Selikoff's research extended far beyond the insulation trade. His findings demonstrated that asbestos exposure posed serious health risks to shipyard workers, construction trades, automotive mechanics, and countless other occupations. Sixty asbestos trusts were established from 1988 onward with about $37 billion in total assets, according to the Government Accountability Office.[4][5]
At a Glance
- The 1964 insulation-worker study — Selikoff's 1964 study of 632 insulation workers recorded 45 deaths from cancer of the lung or pleura against 6.6 expected, and identified three pleural mesotheliomas and one peritoneal, carrying Wagner's South African finding into a U.S. workforce[2]
- Longest-running cohort — Followed 17,800 asbestos insulation workers prospectively for two decades, from 1 January 1967 to 1 January 1987, recording 457 fatal mesothelioma cases
- Leading U.S. expert — Historians McCulloch and Tweedale call him "the leading American medical expert on asbestos-related diseases between the 1960s and early 1990s".[1]
- Time since first exposure — With Peto and Seidman, he reported in 1982 that mesothelioma death rates in asbestos workers "appear to be proportional to the 3rd or 4th power of time from first exposure".[6]
- Lung scarring alongside mesothelioma — A 1987 study of 184 mesothelioma cases (72 pleural and 112 peritoneal) from his insulation-worker cohort found that most patients had both parenchymal and pleural fibrosis on chest x-ray[7]
- Extended protections beyond one trade — Demonstrated that shipyard workers, construction laborers, mechanics, and many other occupations faced serious asbestos risk
- Target of an industry campaign — Historians McCulloch and Tweedale concluded that "most of the attacks on Selikoff were inspired by the asbestos industry or its sympathizers".[1]
- Short survival documented — In that cohort, mean survival from initial presentation to death was 11.4 months for pleural and 7.4 months for peritoneal mesothelioma[3]
Key Facts
| Metric | Finding |
|---|---|
| Landmark Study | 1964 study of 632 asbestos insulation workers |
| Cancer Mortality Rate | Deaths from cancer of the lung and pleura 6.8 times the expected rate |
| Long-Term Cohort | 17,800 asbestos insulation workers observed prospectively from 1 January 1967 to 1 January 1987 |
| Mesothelioma Deaths Documented | 457 fatal pleural and peritoneal cases; mean survival from initial presentation 11.4 months (pleural) vs 7.4 months (peritoneal) |
| Institution | Mount Sinai Hospital, New York |
| Time Since First Exposure | Mesothelioma death rates proportional to the 3rd or 4th power of time from first exposure (Peto, Seidman and Selikoff, 1982)[6] |
| Asbestos Trust System | 60 trusts established from 1988 onward, with about $37 billion in total assets (Government Accountability Office, 2011)[5] |
Who Was Dr. Irving Selikoff?
Dr. Irving J. Selikoff was "a New York physician based at Mount Sinai Hospital", in the words of historians McCulloch and Tweedale.[1] His studies of American asbestos insulation workers documented their excess deaths from cancer of the lung and pleura.[2] While J. Christopher Wagner had established the asbestos-mesothelioma connection in South Africa in 1960, it was Selikoff who brought this critical knowledge to the United States.
Born in 1915, Selikoff was, in McCulloch and Tweedale's assessment, "the leading American medical expert on asbestos-related diseases between the 1960s and early 1990s".[1]
| "Dr. Selikoff's research didn't just change science—it changed law. The OSHA regulations that protect workers today exist in large part because of his courage in standing up to powerful industry interests. Every asbestos exposure limit, every workplace safety standard, every warning label carries his legacy." |
| — Paul Danziger, Co-Founding Partner, Danziger & De Llano |
What Did Dr. Selikoff's 1964 Study Reveal?
In 1964, Dr. Selikoff and colleagues published a study of 632 insulation workers "who entered the trade before 1943 and were traced through 1962".[2] Its main findings:
| Finding | Significance |
|---|---|
| 6.8x Lung and Pleural Cancer Mortality | Forty-five men died of cancer of the lung or pleura, "whereas only 6.6 such deaths were expected" |
| Exceedingly High Mesothelioma Incidence | Four mesotheliomas in 255 deaths, which the authors called "an exceedingly high incidence for such a rare tumor" |
| Digestive-Tract Cancers | The authors reported that "an unexpectedly large number of men died of cancer of the stomach, colon, or rectum (29 compared with 9.4 expected)" |
| Asbestosis Deaths | "Twelve men died of asbestosis" |
How Did Dr. Selikoff's Long-Term Research Strengthen the Evidence?
Selikoff's prospective studies continued for decades after his initial 1964 publication.[3] From 1 January 1967 to 1 January 1987, his team followed the insulation-worker population prospectively, generating even more compelling evidence.
Among the 17,800 insulation workers followed across those twenty years, Selikoff's team recorded 457 consecutive fatal cases of pleural and peritoneal mesothelioma.[3] An earlier analysis drawn from the same cohort examined 184 mesothelioma cases for which chest radiographs of sufficient quality were available — 72 pleural mesothelioma cases and 112 peritoneal mesothelioma cases.[7] A 1982 analysis of mesothelioma mortality in asbestos workers by Peto, Seidman and Selikoff reported two relationships:[6]
- Time-Dependent Risk: Mesothelioma death rates in asbestos workers "appear to be proportional to the 3rd or 4th power of time from first exposure".[6]
- Age Independence: "Age at first exposure has little or no influence", which the authors wrote supports the "multi-stage" model of carcinogenesis.[6]
| "When we investigate our clients' exposure histories, we're applying principles that Dr. Selikoff established decades ago. His research taught us that every asbestos exposure matters, that latency periods can span a lifetime, and that workers who were never warned about the dangers deserve justice." |
| — Rod De Llano, Founding Partner, Danziger & De Llano |
What Federal Asbestos Exposure Limits Apply Today?
Under OSHA's general industry asbestos standard, the employer must ensure that "no employee is exposed to an airborne concentration of asbestos in excess of 0.1 fiber per cubic centimeter of air as an eight (8)-hour time-weighted average (TWA)".[8] The same standard sets an excursion limit: no employee may be exposed above "1.0 fiber per cubic centimeter of air (1 f/cc) as averaged over a sampling period of thirty (30) minutes".[8]
Where Did Dr. Selikoff Do His Research?
Selikoff worked at Mount Sinai in New York. Historians McCulloch and Tweedale describe him as "a New York physician based at Mount Sinai Hospital".[1] His 1992 study with Ribak of survival among insulation workers with mesothelioma lists the Environmental Sciences Laboratory, Mount Sinai School of Medicine, as its affiliation.[3]
How Did the Asbestos Industry Respond to Dr. Selikoff's Research?
Selikoff faced sustained opposition. In McCulloch and Tweedale's account he "was consistently demonized as a media zealot who exaggerated the risks of asbestos on the back of bogus medical qualifications and flawed science".[1]
Historians reviewing the record concluded that most of the attacks on Selikoff were inspired by the asbestos industry or its sympathizers, and that for much of his career he was the subject of a sustained and orchestrated campaign to discredit him.[1]
| "The documents we uncover in mesothelioma cases often show that asbestos companies tried to suppress Dr. Selikoff's research and attack his credibility. They knew he was right—that's exactly why they fought so hard against him. His courage in the face of that opposition saved countless lives." |
| — David Foster, Executive Director of Client Services, Danziger & De Llano |
What Is Dr. Selikoff's Legacy for Mesothelioma Patients Today?
Dr. Irving Selikoff died in 1992.[1] Historians McCulloch and Tweedale conclude that "The most serious criticisms usually more accurately describe his detractors than Selikoff himself".[1]
Frequently Asked Questions
What was Dr. Selikoff's most important discovery?
Dr. Selikoff's 1964 study documented that 45 of 632 American insulation workers died of cancer of the lung or pleura, "whereas only 6.6 such deaths were expected", about 6.8 times the expected number.[2]
What is the OSHA asbestos exposure limit today?
OSHA's general industry standard limits exposure to 0.1 fiber per cubic centimeter of air as an eight-hour time-weighted average, with an excursion limit of 1.0 fiber per cubic centimeter averaged over 30 minutes.[8]
How many workers did Dr. Selikoff study?
Selikoff's initial 1964 study examined 632 asbestos insulation workers. His long-term follow-up expanded to 17,800 asbestos insulation workers observed prospectively from 1 January 1967 to 1 January 1987, among whom 457 fatal mesothelioma cases were recorded.
Why did the asbestos industry oppose Dr. Selikoff?
Historians McCulloch and Tweedale concluded that "most of the attacks on Selikoff were inspired by the asbestos industry or its sympathizers".[1]
Where did Dr. Selikoff do his research?
At Mount Sinai in New York. Historians McCulloch and Tweedale describe him as "a New York physician based at Mount Sinai Hospital".[1] His 1992 mesothelioma survival study with Ribak lists the Environmental Sciences Laboratory, Mount Sinai School of Medicine, as its affiliation.[3]
How long did mesothelioma patients in Dr. Selikoff's cohort survive?
In the cohort of 17,800 asbestos insulation workers observed prospectively from 1 January 1967 to 1 January 1987, mean survival from initial presentation of the disease to death was 11.4 months for pleural mesothelioma and 7.4 months for peritoneal mesothelioma. Mean survival from diagnosis to death was shorter for both groups: 8.4 months for pleural and 5.8 months for peritoneal cases.[3]
What did Dr. Selikoff discover about mesothelioma latency periods?
In a 1982 analysis with Peto and Seidman, Selikoff reported that mesothelioma death rates in asbestos workers "appear to be proportional to the 3rd or 4th power of time from first exposure", and that "Age at first exposure has little or no influence".[6]
Quick Statistics
- 6.8x — The elevated rate of deaths from lung and pleural cancer Selikoff documented among asbestos insulation workers, 45 against 6.6 expected
- 632 — Number of insulation workers in his 1964 study, traced through 1962
- 17,800 — Asbestos insulation workers observed prospectively in his long-term follow-up, 1 January 1967 to 1 January 1987
- 457 — Fatal pleural and peritoneal mesothelioma cases recorded in that cohort
- 72 / 112 — Pleural and peritoneal cases in the 184-case radiographic series drawn from the same cohort
- About $37 billion — Total assets of the 60 asbestos trusts established from 1988 onward, reported by the Government Accountability Office in 2011[5]
Related Pages
- History of Mesothelioma Research
- J. Christopher Wagner
- Asbestos Health Effects
- Mesothelioma Latency Period
- Asbestos History Timeline
- Insulation Workers
- Asbestos Exposure Screening Programs
- Mesothelioma Survival Statistics
- Johns Manville Corporate History
- Dr David Sugarbaker
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Shooting the messenger: the vilification of Irving J. Selikoff., McCulloch J, Tweedale G, Int J Health Serv, 2007;37(4):619-34 (PMID 18072311)
- ↑ 2.0 2.1 2.2 2.3 2.4 SELIKOFF IJ, CHURG J, HAMMOND EC. ASBESTOS EXPOSURE AND NEOPLASIA. JAMA. 1964;188:22-6. PMID: 14107207.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Ribak J, Selikoff IJ. Survival of asbestos insulation workers with mesothelioma. Br J Ind Med. 1992;49(10):732-5. PMID: 1419863.
- ↑ Mesothelioma and Asbestos Trust Fund Payouts, Danziger & De Llano
- ↑ 5.0 5.1 5.2 Asbestos Injury Compensation: The Role and Administration of Asbestos Trusts, GAO-11-819, September 23, 2011, U.S. Government Accountability Office
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982;45(1):124-35. PMID: 7059455.
- ↑ 7.0 7.1 Lilis R, Ribak J, Suzuki Y, et al. Non-malignant chest x ray changes in patients with mesothelioma in a large cohort of asbestos insulation workers. Br J Ind Med. 1987;44(6):402-6. PMID: 3606969.
- ↑ 8.0 8.1 8.2 OSHA Asbestos Standard - General Industry, Occupational Safety and Health Administration